Search Results - "COUZIGOU, P"

Biological or relational screening for liver disease? by Couzigou, P

Get full text

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study by Foucher, J, Chanteloup, E, Vergniol, J, Castéra, L, Le Bail, B, Adhoute, X, Bertet, J, Couzigou, P, de Lédinghen, V

“…Background: Transient elastography (FibroScan) is a new, non-invasive, rapid, and reproducible method allowing evaluation of liver fibrosis by measurement of…”
Get full text

Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E by Perrin, H Blasco, Cintas, P, Abravanel, F, Gérolami, R, d'Alteroche, L, Raynal, J-N, Alric, L, Dupuis, E, Prudhomme, L, Vaucher, E, Couzigou, P, Liversain, J-M, Bureau, C, Vinel, J-P, Kamar, N, Izopet, J, Peron, J-M

“…Neurologic disorders, mainly Guillain-Barré syndrome and Parsonage–Turner syndrome (PTS), have been described in patients with hepatitis E virus (HEV)…”
Get full text

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers by Castéra, L., Bernard, P.‐H., Le Bail, B., Foucher, J., Trimoulet, P., Merrouche, W., Couzigou, P., de Lédinghen, V.

“…Summary Background  Non invasive methods for fibrosis evaluation remain to be validated longitudinally in hepatitis B. Aim  To evaluate longitudinally…”
Get full text

Changes of non-invasive markers and FibroScan values during HCV treatment by Vergniol, J., Foucher, J., Castéra, L., Bernard, P.-H., Tournan, R., Terrebonne, E., Chanteloup, E., Merrouche, W., Couzigou, P., De Lédinghen, V.

“…The recent advent of non‐invasive methods for assessment of fibrosis allows serial assessments in all patients with hepatitis C. The aim of this prospective…”
Get full text

Evidence of Viral Replication in Circulating Dendritic Cells during Hepatitis C Virus Infection by Goutagny, Nadège, Fatmi, Ahmed, Ledinghen, Victor De, Penin, François, Couzigou, Patrice, Inchauspé, Geneviève, Bain, Christine

“…The existence of extrahepatic sites of hepatitis C virus (HCV) replication has been proposed as a mechanism responsible for the poor antiviral immune response…”
Get full text

Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate by LAHARIE, D., ZERBIB, F., ADHOUTE, X., BOUÉ‐LAHORGUE, X., FOUCHER, J., CASTÉRA, L., RULLIER, A., BERTET, J., COUZIGOU, P., AMOURETTI, M., DE LÉDINGHEN, V.

“…Summary Background Methotrexate is an effective treatment in Crohn's disease, which may induce liver fibrosis with high cumulative doses. Transient…”
Get full text

Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring by Staub, F., Tournoux-Facon, C., Roumy, J., Chaigneau, C., Morichaut-Beauchant, M., Levillain, P., Prevost, C., Aubé, C., Lebigot, J., Oberti, F., Galtier, J. B., Laumonier, H., Trillaud, H., Bernard, P. H., Blanc, J. F., Sironneau, S., Machet, F., Drouillard, J., de Ledinghen, V., Couzigou, P., Foucher, P., Castéra, L., Tranquard, F., Bacq, Y., d’Altéroche, L., Ingrand, P., Tasu, J. P.

“…We prospectively assessed contrast-enhanced sonography for evaluating the degree of liver fibrosis as diagnosed via biopsy in 99 patients. The transit time of…”
Get full text

P693 NEUROLOGIC DISORDERS DURING HEV INFECTION IN NONIMMUNOCOMPROMISED PATIENTS by Perrin, H. Blasco, Cintas, P, Abravanel, F, Gérolami, R, Couzigou, P, d'Alteroche, L, Prudhomme, L, Buscail, L, Bureau, C, Vinel, J.P, Izopet, J, Peron, J.M

Get full text

Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C by CASTERA, L., CONSTANT, A., HENRY, C., CHAMPBENOIT, P., BERNARD, P.‐H., DE LEDINGHEN, V., DEMOTES‐MAINARD, J., COUZIGOU, P.

“…Summary Background The psychiatric side effects of interferon, often responsible for dose reduction or treatment discontinuation, represent a major limitation…”
Get full text

Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study by de Lédinghen, Victor, Lecesne, Robin, Raymond, Jean-Michel, Gense, Véronique, Amouretti, Michel, Drouillard, Jacques, Couzigou, Patrice, Silvain, Christine

“…Background: Endoscopic ultrasonography (EUS) appears to be the best imaging method for the diagnosis of choledocholithiasis. The aim of this preliminary,…”
Get full text

Hepatitis C Virus Genotyping Based on 5′ Noncoding Sequence Analysis (Trugene) by HALFON, P, TRIMOULET, P, OUZAN, D, BOURLIERE, M, KHIRI, H, DE LEDINGHEN, V, COUZIGOU, P, FERYN, J. M, ALCARAZ, P, RENOU, C, FLEURY, H. J. A

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C by BREILH, D., FOUCHER, J., CASTÉRA, L., TRIMOULET, P., DJABAROUTI, S., MERROUCHE, W., COUZIGOU, P., SAUX, M.‐C., DE LÉDINGHEN, V.

“…Summary Background  The main goal of therapy in hepatitis C virus (HCV) infection is to achieve a sustained virological response (SVR). However, the impact of…”
Get full text

Epidemiological factors affecting the severity of hepatitis C virus‐related liver disease: A French survey of 6,664 patients by Roudot‐Thoraval, F, Bastie, A, Pawlotsky, J, Dhumeaux, D

“…Cirrhosis is a frequent and severe event in the course of chronic hepatitis C, but it is unclear why some patients develop cirrhosis after a given period…”
Get full text

392 LONGITUDINAL ASSESSMENT OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AND FOUR BIOMARKERS IN HCV PATIENTS WITH F3–F4 FIBROSIS: RELATIONSHIP WITH ANTIVIRAL TREATMENT RESPONSE AND CLINICAL OUTCOME by Castera, L, Bernard, P.-H, Le Bail, B, Foucher, J, Merrouche, W, Couzigou, P, de Ledinghen, V

Get full text

283 HCV PROTEASE INHIBITOR RESTORES INSULIN SENSITIVITY IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS by Moucari, R, Forestier, N, Larrey, D, Guyader, D, Couzigou, P, Benhamou, Y, Voitot, H, Vidaud, M, Seiwert, S, Bradford, B, Zeuzem, S, Marcellin, P

Get full text

231 PROGNOSTIC VALUE OF TRANSIENT ELASTOGRAPHY AND NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE. A PROSPECTIVE ANALYSIS OF 4,935 PERSON-YEARS by Vergniol, J, Foucher, J, Terrebonne, E, Font, J, Merrouche, W, Couzigou, P, de Ledinghen, V

Get full text

127 PREVALENCE AND FACTORS ASSOCIATED WITH LIVER STIFFNESS MEASUREMENT FAILURE AND UNRELIABLE RESULTS USING FIBROSCAN: A 5 YEAR EXPERIENCE IN 13369 EXAMINATIONS by Castera, L, Foucher, J, Bernard, P.-H, Carvalho, F, Allaix, D, Merrouche, W, Couzigou, P, de Ledinghen, V

Get full text

Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases by Cogrel, O., Doutre, M.S., Marlière, V., Beylot‐Barry, M., Couzigou, P., Beylot, C.

“…Interferon‐induced sarcoidosis is well documented. We report two new cases of sarcoidosis in two patients with hepatitis C virus infection treated with…”
Get full text

Ribavirin Posology, Observance, and Sustained Virologic Response by Couzigou, P, Foucher, J, Castera, L, De Ledinghen, V

Get full text